Contract facts
UnrestrictedNo full NAICS 562112 intel page yet. Browse NAICS intelligence
PHARMACEUTICAL REVERSE DISTRIBUTION AND WASTE PICKUP is a federal Unrestricted award for 248-Network Contract Office 8 (36C248) held by Inmar Rx Solutions Inc. Estimated value $1.2M ($770K obligated). Current period of performance ends Jan 16, 2027 (potential Jan 16, 2028). Last award drew 4 bidders. Place of performance: GAINESVILLE FL. Related solicitation 36C24823Q0052.
PHARMACEUTICAL REVERSE DISTRIBUTION AND WASTE PICKUP
Recompete timing
PublicCurrent PoP ends Jan 16, 2027 (111 days remaining). Agencies typically plan 12–18 months ahead — at 3.6 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C24823P0378? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordInmar Rx Solutions Inc — $101.5M obligated across 10 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24823P0378?
36C24823P0378 (Pharmaceutical reverse distribution and WASTE) is a 248-Network Contract Office 8 (36C248) award with a potential value of $1.2M, currently held by Inmar Rx Solutions Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C248-23-P-0378?
36C248-23-P-0378 is the dashed form of PIID 36C24823P0378 (Pharmaceutical reverse distribution and WASTE), held by Inmar Rx Solutions Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24823P0378?
248-Network Contract Office 8 (36C248) awarded 36C24823P0378 to Inmar Rx Solutions Inc (potential $1.2M).
Who is the incumbent on 36C24823P0378?
Inmar Rx Solutions Inc is the incumbent with $101.5M across 10 related awards in SCOUT’s public footprint. The current period of performance ends Jan 16, 2027.
When does Inmar Rx Solutions Inc’s 36C24823P0378 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 16, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24823P0378? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.